A synergistic impact of body mass index and gamma gap on heart failure and mortality rate among older patients with coronary artery disease: a prospective study with 10-year follow-up

Fu S, Luo L, Ye P, Liu Y, Zhu B, Bai Y, et al. The abilities of new anthropometric indices in identifying cardiometabolic abnormalities, and influence of residence area and lifestyle on these anthropometric indices in a Chinese community-dwelling population. Clin Interv Aging. 2014;9:179–89.

Article  PubMed  PubMed Central  Google Scholar 

Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;394:1145–58.

Article  PubMed  PubMed Central  Google Scholar 

Şaylık F, Çınar T, Hayıroğlu Mİ. Effect of the obesity paradox on mortality in patients with acute coronary syndrome: a comprehensive meta-analysis of the literature. Balkan Med J. 2023;40:93–103.

Article  PubMed  PubMed Central  Google Scholar 

Qu Y, Yang J, Zhang F, Li C, Dai Y, Yang H, et al. Relationship between body mass index and outcomes of coronary artery disease in Asian population: Insight from the FOCUS registry. Int J Cardiol. 2020;300:262–7.

Article  PubMed  Google Scholar 

Edwards MK, Loprinzi PD. The Association of Estimated Cardiorespiratory Fitness on mortality risk among those with an elevated gamma gap. Int J Cardiol. 2017;227:508–10.

Article  PubMed  Google Scholar 

Juraschek SP, Moliterno AR, Checkley W, Miller ER. The Gamma Gap and All-Cause Mortality. PLoS One. 2015;10:e0143494.

Article  PubMed  PubMed Central  Google Scholar 

Skalidis EI, Vardas PE. Guidelines on the management of stable angina pectoris. Eur Heart J. 2006;27:2606.

Article  PubMed  Google Scholar 

Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007;50:e1–157.

Article  PubMed  Google Scholar 

Lavie CJ, Milani RV. Obesity and cardiovascular disease: the hippocrates paradox? J Am Coll Cardiol. 2003;42:677–9.

Article  PubMed  Google Scholar 

Hwang I-C, Choi H-M, Yoon YE, Park JJ, Park J-B, Park J-H, et al. Body Mass Index, Muscle Mass, and All-Cause Mortality in Patients With Acute Heart Failure: The Obesity Paradox Revisited. Int J Heart Fail. 2022;4:95–109.

Article  PubMed  PubMed Central  Google Scholar 

Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305–13.

Article  PubMed  Google Scholar 

Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49–73.

Article  PubMed  Google Scholar 

Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LAM, Skali H, et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2007;116:627–36.

Article  PubMed  Google Scholar 

Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M. ADHERE Scientific Advisory Committee and Investigators. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J. 2007;153:74–81.

Article  PubMed  Google Scholar 

Stienen S, Ferreira JP, Girerd N, Duarte K, Lamiral Z, McMurray JJV, et al. Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative. Clin Res Cardiol. 2019;108:1215–25.

Article  PubMed  Google Scholar 

Yui H, Ebisawa S, Miura T, Nakamura C, Maruyama S, Kashiwagi D, et al. Impact of changes in body mass index after percutaneous coronary intervention on long-term outcomes in patients with coronary artery disease. Heart Vessels. 2020;35:1657–63.

Article  PubMed  Google Scholar 

Yang M, Xie L, Liu X, Hao Q, Jiang J, Dong B. The gamma gap predicts 4-year all-cause mortality among nonagenarians and centenarians. Sci Rep. 2018;8:1046.

Article  PubMed  PubMed Central  Google Scholar 

Dalle S, Rossmeislova L, Koppo K. The Role of Inflammation in Age-Related Sarcopenia. Front Physiol. 2017;8:1045.

Article  PubMed  PubMed Central  Google Scholar 

Guo X, Ma L. Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol-related inflammatory parameters as predictors. Coron Artery Dis. 2023;34:66–77.

Article  PubMed  Google Scholar 

Pai AY, Sy J, Kim J, Kleine C-E, Edward J, Hsiung J-T, et al. Association of serum globulin with all-cause mortality in incident hemodialysis patients. Nephrol Dial Transplant. 2021;37:1993–2003.

Article  PubMed Central  Google Scholar 

Meng Q, Liu H, Liu J, Pang Y, Liu Q. Advances in immunotherapy modalities for atherosclerosis. Front Pharmacol. 2022;13:1079185.

Article  CAS  PubMed  Google Scholar 

Pattarabanjird T, Li C, McNamara C. B Cells in Atherosclerosis: Mechanisms and Potential Clinical Applications. JACC Basic Transl Sci. 2021;6:546–63.

Article  PubMed  PubMed Central  Google Scholar 

Hayıroğlu Mİ, Çınar T, Çinier G, Yüksel G, Pay L, Keskin K, et al. Cardiac variables associated with atrial fibrillation occurrence and mortality in octogenarians implanted with dual chamber permanent pacemakers. Aging Clin Exp Res. 2022;34:2533–9.

Article  PubMed  Google Scholar 

Hayıroğlu Mİ, Çınar T, Çinier G, Yüksel G, Pay L, Keskin K, et al. Prognostic value of serum albumin for long-term mortality in patients with dual-chamber permanent pacemakers. Biomark Med. 2022;16:341–8.

Article  PubMed  Google Scholar 

Anker SD, von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart. 2004;90:464–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Çinier G, Hayıroğlu Mİ, Kolak Z, Tezen O, Yumurtaş AÇ, Pay L, et al. The value of C-reactive protein-to-albumin ratio in predicting long-term mortality among HFrEF patients with implantable cardiac defibrillators. Eur J Clin Invest. 2021;51:e13550.

Article  PubMed  Google Scholar 

Niedziela JT, Hudzik B, Szygula-Jurkiewicz B, Nowak JU, Polonski L, Gasior M, et al. Albumin-to-globulin ratio as an independent predictor of mortality in chronic heart failure. Biomark Med. 2018;12:749–57.

Article  CAS  PubMed  Google Scholar 

van den Hoogen P, de Jager SCA, Huibers MMH, Schoneveld AH, Puspitasari YM, Valstar GB, et al. Increased circulating IgG levels, myocardial immune cells and IgG deposits support a role for an immune response in pre- and end-stage heart failure. J Cell Mol Med. 2019;23:7505–16.

Article  PubMed  PubMed Central  Google Scholar 

Fu S, Luo L, Ye P, Liu Y, Zhu B, Zheng J, et al. Overall and abdominal obesity indicators had different association with central arterial stiffness and hemodynamics independent of age, sex, blood pressure, glucose, and lipids in Chinese community-dwelling adults. Clin Interv Aging. 2013;8:1579–84.

Article  PubMed  PubMed Central  Google Scholar 

Brunetti L, Chapy H, Nahass RG, Moore R, Wassef A, Adler D, et al. Relationship between Body Composition and Serum Immunoglobulin Concentrations after Administration of Intravenous Immune Globulin–Preclinical and Clinical Evidence. Pharmaceutics. 2023;15:510.

Article  CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif